TNF-α and IL-1β Selectively Induce Expression of 92-kDa Gelatinase by Human Macrophages

Journal of Immunology

Volumn 157, Issue 9, 1996, Pages 4159-4165

  Sarén, Pirjo ^a   Welgus, Howard G ^b   Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GAMMA INTERFERON; GELATINASE; GLYCOPROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; EXTRACELLULAR MATRIX; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MONOCYTE;

CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGENASES; ENZYME INDUCTION; EXTRACELLULAR MATRIX; GELATINASES; GLYCOPROTEINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGES; MATRIX METALLOPROTEINASE 3; MONOCYTES; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030292766     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Matrisian, L. M. 1992. The matrix-degrading metalloproteinases. BioEssays 14: 455.
2. Okada, Y., N. Takeuchi, K. Tomita, I. Nakanishi, and H. Nagase. 1989. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann. Rheum. Dis. 48:645.
3. Dean, D. D., J. Martel-Pelletier, J.-P. Pelletier, D. S. Howell, and J. Woessner, J. F. 1989. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J. Clin. Invest. 84:678.
4. Galis, Z. S., G. K. Sukhova, M. W. Lark, and P. Libby. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493.
5. Welgus, H. G., E. J. Campbell, Z. Bar-Shavit, R. M. Senior, and S. L. Teitelbaum. 1985. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J. Clin. Invest. 76:219.
6. Denhardt, D. T., B. Feng, D. R. Edwards, E. T. Cocuzzi, and U. M. Malyankar. 1993. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol. Ther. 59:329.
7. Hibbs, M. S., J. R. Hoidal, and A. H. Kang. 1987. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J. Clin. Invest. 80:1644.
8. Welgus, H. G., E. J. Campbell, J. D. Cury, A. Z. Eisen, R. M. Senior, S. M. Wilhelm, and G. I. Goldberg. 1990. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86:1496.
9. Cury, J. D., E. J. Campbell, C. J. Lazarus, R. J. Albin, and H. G. Welgus. 1988. Selective up-regulation of human alveolar macrophage collagenase production by lipopolysaccharide and comparison to collagenase production by fibroblasts. J. Immunol. 141:4306.
10. Katsuda, S., Y. Okada, Y. Okada, K. Imai, and I. Nakanishi. 1994. Matrix metalloproteinase-9 (92-kDa gelatinase/type IV collagenase equals gelatinase B) can degrade arterial elastin. Am. J. Pathol. 145:1208.
11. Murphy, G., M. I. Cockett, R. V. Ward, and A. J. P. Docherty. 1991. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: a quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277:277.
12. Matrisian, L. M. 1990. Metalloproteinases and their inhibitors in matrix remodeling. Trends. Genet. 6:121.
13. Lacraz, S., L. P. Nicod, R. Chicheportiche, H. G. Welgus, and J.-M. Dayer. 1995. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest. 96:2304.
14. Leco, K. J., R. Khokha, N. Pavloff, S. P. Hawkes, and D. R. Edwards. 1994. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269:9352.
15. Dinarello, C. A. 1992. Role of interleukin-1 and tumor necrosis factor in systemic responses to infection and inflammation. In Inflammation: Basic principles and clinical correlates. 2nd Ed. J. I. Gallin, I. M. Goldstein and R. Snyderman, eds. Raven Press, Ltd., New York, p. 211.
16. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNFα/cachectin. Nature 346:274.
17. Meikle, M. C., S. J. Atkinson, R. V. Ward, G. Murphy, and J. J. Reynolds. 1989. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: Evidence that breakdown is mediated by metalloproteinases. J. Periodont. Res. 24:207.
18. Shapiro, S. D., E. J. Campbell, D. K. Kobayashi, and H. G. Welgus. 1990. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J. Clin. Invest. 86:1204.
19. Nathan, C. 1992. Interferon and inflammation. In Inflammation: Basic principles and clinical correlates. 2nd Ed. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, Ltd., New York, p. 265.
20. Adams, D. O., and T. A. Hamilton. 1987. Molecular transductional mechanisms by which IFN-gamma and other signals regulate macrophage development. Immunol. Rev. 97:5.
21. Ohmori, Y., and T. A. Hamilton. 1994. Regulation of macrophage gene expression by T-cell-derived lymphokines. Pharmacol. Ther. 63:235.
22. Cooper, T. W., E. A. Bauer, and A. Z. Eisen. 1982. Enzyme-linked immunosorbent assay for human skin collagenase. Collagen Relat Res. 3:205.
23. Wilhelm, S. M., I. E. Collier, A. Kronberger, A. Z. Eisen, B. L. Marmer, G. A. Grant, E. A. Bauer, and G. I. Goldberg. 1987. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc. Natl. Acad. Sci. USA 84:6725.
24. Saarialho-Kere, U. K., H. G. Welgus, and W. C. Parks. 1993. Distinct mechanisms regulate interstitial collagenase and 92 kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. J. Biol. Chem. 268:17354.
25. Welgus, H. G., and G. P. Stricklin. 1983. Human skin fibroblast collagenase inhibitor. Comparative studies in human tissues, serum, and amniotic fluid. J. Biol. Chem. 258:12259.
26. Sorger, T., and R. J. Germinario. 1983. A direct solubilization procedure for the determination of DNA and protein in cultured fibroblast monolayer. Anal. Biochem. 131:254.
27. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.
28. Wilhelm, S. M., I. E. Collier, B. L. Marmer, A. Z. Eisen, G. A. Grant, and G. I. Goldberg. 1989. SV 40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:17213.
29. Stähle-Bäckdahl, M., B. D. Sudbeck, A. Z. Eisen, H. G. Welgus, and W. C. Parks. 1992. Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma. J. Invest. Dermatol. 99:497.
30. Campbell, E. J., J. D. Cury, S. D. Shapiro, G. I. Goldberg, and H. G. Welgus. 1991. Neutral proteinases of human mononuclear phagocytes: cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J. Immunol. 146:1286.
31. Zembala, M., and G. L. Asherson. 1989. Human monocytes. Academic Press, San Diego, p. 1.
32. Galis, Z. S., M. Muszynski, G. K. Sukhova, E. Simon-Morrissey, E. N. Unemori, M. W. Lark, E. Amento, and P. Libby. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75:181.
33. Panagakos, F. S., and S. Kumar. 1994. Modulation of proteases and their inhibitors in immortal human osteoblast-like cells by tumor necrosis factor-alpha in vitro. Inflammation 18:243.
34. Unemori, E. N., M. S. Hibbs, and E. P. Amento. 1991. Constitutive expression of a 92-kD gelatinase (type IV collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J. Clin. Invest. 88:1656.
35. Mackay, A. R., M. Ballin, M. D. Pelina, A. R. Farina, A. M. Nason, J. L. Hartzler, and U. P. Thorgeirsson. 1992. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteirase expression in tumor and normal cell lines. Invasion Metastasis 12:168.
36. Henney, A. M., P. R. Wakeley, M. J. Davies, K. Foster, R. Hembry, G. Murphy, and S. Humphries. 1991. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA 88:8154.
37. Lacraz, S., L. Nicod, B. Galve-de Rochemonteix, C. Baumberger, J.-M. Dayer, and H. G. Welgus. 1992. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90:382.
38. Tamai, K., H. Ishikawa, A. Mauviel, and J. Uitto. 1995. Interferon-gamma coordinately upregulates matrix metalloproteinase MMP-1 and MMP-3, but not tissue inhibitor of metalloproteinases (TIMP), expression in cultured keratinocytes. J. Invest. Dermatol. 104:384.
39. Brown, D. L., M. S. Hibbs, M. Kearney, C. Loushin, and J. M. Isner. 1994. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 91:2125.
40. Thompson, R. W., D. R. Holmes, R. A. Mertens, S. Liao, M. D. Botney, R. P. Mecham, H. G. Welgus, and W. C. Parks. 1995. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 96: 318.
41. Barath, P., M. C. Fishbein, J. Cao, J. Berenson, R. H. Helfant, and J. S. Forrester. 1990. Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 65:297.
42. Kaartinen, M., A. Penttilä, and P. T. Kovanen. 1996. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-α. Circulation. In press.
43. Moyer, C. F., D. Sajuthi, H. Tulli, and J. K. Williams. 1991. Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am. J. Pathol. 138:951.
44. Stemme, S., and G. K. Hansson. 1994. Immune mechanisms in atherosclerosis. Coron. Artery. Dis. 5:216.